Home / Drug shortages / Dexmedetomidine Hydrochloride Injection

Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 04/10/2020. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9532-25
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)
Initial Posting
04/10/2020
Revised Date

Reason

Demand increase for the drug

FDA data resources